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Abstract 
Background: Sarcopenia, osteoporosis and osteoarthritis are the most frequent musculoskeletal disorders affecting 
older people. The main aim of this study was to test the hypothesis that the balance between BMPs and myostatin 
pathways regulates the age-related muscle degeneration in OP and OA patients. To this end, we investigated the 
relationship among the expression of BMP-2/4-7, myostatin and phosphorylated Smads1-5-8 and the muscle quality, 
evaluated in term of fibers atrophy and satellite cells activity.
Methods: In this retrospective study, we collected 123 biopsies of vastus lateralis: 48 biopsies from patients who 
underwent hip arthroplasty for subcapital fractures of the femur (OP), 55 biopsies from patients who underwent hip 
arthroplasty for osteoarthritis (OA) and 20 biopsies from patients who underwent hip arthroplasty for high-energy 
hip fractures (CTRL). Muscle biopsies were fixed in 4% paraformaldehyde and paraffin embedded. Serial sections were 
used for morphometrical and immunohistochemical analysis (BMP/2/4-7, myostatin, Smads1-5-8, Pax7 and myo-
genin). In addition, 1 mm3 of muscle tissue of each patient was embedded in epon for ultrastructural study.
Results: Morphometric data indicated an increase of the number of atrophic fibers in OP patients compare to OA. In 
line with these data, we found an high regenerative potential in muscle tissues of OA patients due to the significant 
amount of both Pax7 and myogenin positive satellite cells detected in OA group. In addition, our data showed the 
decrease of BMP2/4 and -7 expression in OP patients compared to both OA group and CTRL. Conversely, OP patients 
were characterized by high levels of myostatin expression. A different expression profile was also found for phospho-
rylated Smad1-5-8 between OP and OA patients. In particular, OP patients showed a low number of positive phos-
phorylated Smad1-5-8 nuclei.
Conclusion: The identification of molecular pathways involved in the pathogenesis of sarcopenia open new pro-
spective for the development of drugs able to prevent/treat the muscle impairment that occur in elderly. Results here 
reported, highlighting the role of BMPs and myostatin pathways in physio-pathogenesis of human sarcopenia, allow 
us to propose human recombinant BMP-2/7 and anti-myostatin antibodies as a possible therapeutic option for the 
sarcopenia.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Sarcopenia is an aging-induced generalized pathologi-
cal condition characterized by loss of muscle mass and 
function related to aging [1, 2]. It is strongly associated 
to reduction of the global physical strength and poor 
quality of life¸ ultimately the patient experiences fall 
and fractures and is confined to bed with an increased 
risk of mortality [3]. Osteoporosis (OP), osteoarthritis 
(OA) and sarcopenia are the most frequent musculo-
skeletal disorders affecting older people [4, 5]. Indeed, 
aging process is a factor involved in the loss of the func-
tionality of both bone and muscle [6, 7]. In this context, 
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Proteins (BMPs) may play an important role in both 
muscle and bone homeostasis [8]. The BMPs are mol-
ecules of transforming growth factor-β (TGF-β) fam-
ily that orchestrates various biological processes linked 
to cell proliferation, differentiation, morphogenesis, 
cell homeostasis and regeneration [9]. Recently, we and 
others groups have shown that the BMPs expression 
has a role in controlling adult skeletal muscle mass and 
regeneration [10–12]. In particular, we found an asso-
ciation between BMP-2 and BMP-4 expression and the 
activity of satellite stem cells [13]. Among BMPs family 
have been identified numerous molecules with positive 
and/or negative effects on muscle cells [8]. As concern 
BMP-7, recent studies demonstrated their ability to 
block/reduce muscle atrophy after denervation [14]. In 
the canonical signaling pathway, they initiate the signal 
transduction cascade by binding BMP-receptors and 
activating Smad (small mother against decapentaple-
gic) proteins. The Smads involved in BMP signaling are 
Smad1, Smad5, and Smad8 (Smad1/5/8) [15]. Activated 
Smads then associate with the Smad4, and translocates 
to the nucleus where it functions as a transcription fac-
tor regulating the expression of gene involved in muscle 
homeostasis, such as MyoD [16]. Myostatin is a member 
of the TGF-β superfamily and acts as a potent negative 
regulator of skeletal muscle growth [17]. It is known to 
affect muscle mass by negative regulation of myogen-
esis [18]. Indeed, in  vitro experiments have shown that 
myostatin blocks myoblast proliferation and satellite 
cell proliferation and self-renewal by down regulation 
of MyoD [19]. Myostatin induced the blocks of muscle 
regeneration competing both for the binding with BMP-
receptor and activation of Smad4. Thus, the balance 
between myostatin and BMP signaling strongly influence 
the muscle quality.
The main aim of this study was to test the hypothesis 
that the balance between BMPs and myostatin pathways 
regulates the age-related muscle degeneration in OP and 
OA patients. To this end, we investigated the relation-
ship among the expression of BMP-2/4-7, myostatin and 
phosphorylated Smads1-5-8 and the muscle quality, eval-
uated in term of fibers atrophy and satellite cells activity.
Methods
Patients
We enrolled 123 patients who underwent hip surgery 
in the Orthopedic Department of “Tor Vergata” Univer-
sity Hospital in the period June 2014–February 2015. 
We enrolled 48 consecutive patients who underwent 
hip arthroplasty for subcapital fractures of the femur (35 
women and 13 men), 55 consecutive patients who under-
went hip arthroplasty for osteoarthritis (40 women and 
15 men and 20 consecutive patients under 50 (8 women 
and 12 men) who underwent hip arthroplasty for high-
energy hip fractures (CTRL). Exclusion criteria were 
history of cancer, myopathies or other neuromuscular 
diseases or chronic administration of corticosteroid for 
autoimmune diseases (more than 1  month), diabetes, 
alcohol abuse, and HBV, HCV, or HIV infections.
Bone mineral density evaluation (DXA)
DXA was performed with a Lunar DXA apparatus (GE 
Healthcare, Madison, WI, USA). Lumbar spine (L1–L4) 
and femoral (neck and total) scans were performed, and 
bone mineral density (BMD) was measured according to 
manufacture recommendations [20]. Dual-energy X-ray 
absorptiometry measures BMD (in grams per square 
centimeter), with a coefficient of variation of 0.7%. For 
patients with fragility fractures, BMD was measured on 
the uninjured limb. For all the other patients, measure-
ments were performed on the non-dominant side, with 
the participants supine on an examination table with their 
limbs slightly abducted [21]. DXA exam was performed 
1 day before surgery for osteoarthritis patients (OA), and 
1 months after surgery for osteoporotic (OP) and CTRL 
patients. The results were expressed as T-scores.
Radiological evaluation
Hip X-rays were performed in order to check the fracture 
or to assess hip osteoarthritis. Kellgren–Lawrence scale 
was used in order to determine the severity of osteoar-
thritis. The Kellgren and Lawrence system is a method of 
classifying the severity of osteoarthritis (OA) using five 
grades. This classification was proposed by Kellgren et al. 
in 1957 [22]. It includes: grade 0 if no radiographic fea-
tures of OA are present; grade 1 if doubtful joint space 
narrowing (JSN) and possible osteophytic lipping; grade 
2 if definite osteophytes and possible JSN on anteroposte-
rior weight-bearing radiograph; grade 3 if multiple osteo-
phytes, definite JSN, sclerosis, possible bony deformity; 
grade 4 if large osteophytes, marked JSN, severe sclerosis 
and definite bony deformity. Two orthopedists indepen-
dently assessed all radiographs. Patients with a grade of 
K –L  ≥  2 were considered osteoarthritic.
Sampling
During open surgery for hip arthroplasty muscle biopsies 
were taken from the upper portion of the vastus later-
alis. Sample withdrawals were performed for histologi-
cal analysis excluding macroscopic alteration of skeletal 
muscle biopsy as necrosis areas.
Histology
Muscle biopsies were fixed in 4% paraformaldehyde for 
24  h and paraffin embedded. Three-micrometer thick 
sections were stained with hematoxylin and eosin (H&E) 
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and the histological evaluation blindly was performed by 
two pathologists.
Morphometric analysis
In order to assess fibers atrophy, a minimum of 250 mus-
cle fibers per biopsy have been evaluated, comparing 
minimum transverse diameter and cross-sectional area of 
type I and type II fibers for relative prevalence. A thresh-
old diameter lower than 30  μm (minimum value of the 
normal range for women) characterized atrophic fibers.
Immunohistochemistry
BMP-2, BMP-4, BMP-7, myostatin, phosphorylated 
Smads1-5-8, Pax7 and myogenin expression were assed in 
muscle biopsies by immunohistochemistry. Briefly, anti-
gen retrieval was performed on 4-μm-thick paraffin sec-
tions using EDTA citrate pH 7.8 or Citrate pH 6.0 buffers 
for 30 min at 95 °C. Sections were then incubated for 1 h 
at room temperature with primary antibodies (listed in 
Table  1). Washings were performed with PBS/Tween20 
pH 7.6. Reactions were revealed by HRP–DAB Detection 
Kit (UCS Diagnostic, Rome, Italy). Immunohistochemis-
try was evaluated by two blind observers by counting the 
number of positive fibers (out of a total of 500 in randomly 
selected regions) for BMP-2, BMP-4, myiostatin and Smads 
reaction, and by counting the number of positive satellite 
cells for Pax7 and myogenin expression. To assess the back-
ground of immuno-staining, for each reaction, we included 
a negative control, incubating the sections with secondary 
antibodies (HRP) and a detection system (DAB).
Transmission electron microscopy (TEM)
One cubic millimetre of muscle tissue from surgical spec-
imens were fixed in 4% paraformaldehyde and post-fixed 
in 2% osmium tetroxide [23]. After washing with 0.1 M 
phosphate buffer, the sample was dehydrated by a series 
of incubations in 30, 50 and 70% ethanol. Dehydration 
was continued by incubation steps in 95% ethanol, abso-
lute ethanol and propylene oxide, after which samples 
were embedded in Epon (Agar Scientific, Stansted, Essex 
CM24 8GF United Kingdom) [24]. Eighty µm ultra-thin 
sections were mounted on copper grids and examined 
with a transmission electron microscope (Model 7100FA, 
Hitachi, Schaumburg, IL, USA).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 
5 Software (La Jolla, CA, USA). Immunohistochemical 
data were analyzed by One way Anova test (group effect) 
and Mann–Whitney test (p < 0.0005).
Results
Clinical evaluation
The OP group included 48 patients with fragility hip 
fracture, T-score  ≤  −2.5 SD and K–L score from 0 
to 1. The OA group included 55 patients with radio-
graphic evidence of hip OA with a K–L score 3 or 4 and 
T-score ≥ −2.5 SD (Table 2). There was no discrepancy 
for age, sex and comorbidities in the two groups (women, 
mean age OP 73 ± 3.2y OA 71 ± 4.1y) (Table 2). No sig-
nificant differences were found in BMI values between 
Table 1 Primary antibodies used for immunohystochemical reactions
Antibody Characteristics Dilution Retrieval
Anti-Pax7 Rabbit monoclonal, clone NC, Novus Biologicals 1:100 Citrate pH 6.0
Anti-myogenin Rabbit monoclonal, clone F5D, AbCam Cambridge, UK 1:100 EDTA citrate pH 8.0
Anti-BMP-2 Rabbit clone N/A; Novus Biologicals, Littleton, CO, USA 1:100 Citrate pH 6.0
Anti-BMP-4 Rabbit polyclonal clone NBP1-91805; Novus Biologicals, Littleton, CO, USA 1:500 Citrate pH 6.0
Anti-BMP-7 Mouse monoclonal clone ab54904; AbCam, Cambridge, UK 1:250 Citrate pH 6.0
Anti-myostatin Rabbit monoclonal, clone ab134682, AbCam, Cambridge, UK 1:100 EDTA citrate pH 8.0
Anti-Smad1-5-8 Rabbit polyclonal, clone ab13723, AbCam, Cambridge, UK 1:100 EDTA citrate pH 8.0
Table 2 Main characteristics of OA, OP and CTRL patients
Asterisks represent the significance level of the performed test (*P < 0.05, **P < 0.01, ***P < 0.001)
OA OP CTRL T test
(Mann–Whitney test)
Age 71.00 ± 4.01 73.00 ± 3.20 44.23 ± 2.77 OP vs OA ns (P = 0.11); OP vs CTRL *** (P < 0.001); OA vs CTRL *** (P < 0.001)
BMI (kg/m2) 26.59 ± 0.78 25,61 ± 1.13 – ns (P = 0.4467)
T score (L1–L4) −0.71 ± 0.4 −2.85 ± 0.15 0.95 ± 0.01 OA vs OP *** (P < 0.0001)
T score (neck) −0.64 ± 0.11 −2.77 ± 0.19 0.19 ± 0.05 *** (P = 0.0005)
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the two groups (BMI mean values: OP, 26.59 ± 0.78 kg/
m2; OA, 26.59 ± 0.78 kg/m2). CTRL patients were char-
acterized by a T-score ≥ −1.0 SD and K–L score from 0 
to 1.
Morphometric examination
Slow myosin antibody and fast myosin antibody stains 
allowed us to discriminate type I and type II fibers, 
respectively (Fig.  1). As already described [7, 11–13], 
OA and OP patients showed different pattern of fib-
ers atrophy. In particular, OA patients showed about 
30.00% of atrophic fibers with a diameter of less than 
30  μm (16.81  ±  1.21% type I and 18.90  ±  1.24% type 
II) (Fig.  1a), whereas in OP group, we observed about 
50.00% of atrophic fibers with prevalence of type II fibers 
(19.13 ± 2.07% type I and 29.41 ± 2.56% type II) (Fig. 1b). 
Control patients showed a percentage of atrophic fib-
ers less than 15% (Fig. 1c). No significant difference was 
observed between genders.
Immunohistochemical analysis of satellite cells
Immunohistochemistry results of Pax7 and myogenin 
expression were quantified by counting the number of 
positive satellite cells in 25 High Power Field (HPF) of 
randomly selected regions (Fig. 2). Our results showed a 
decrease of the number of both Pax7 and myogenin posi-
tive satellite cells in OP patients as compared to both OA 
and CTRL (Fig.  2a). In particular, Mann–Whitney test 
displayed a greater significant difference for the num-
ber of Pax7 positive satellite cells (OA 32.40 ± 3.70, OP 
15.75 ± 2.85 p = 0.0075) (Fig. 2a–c) respect to myogenin 
(OA 8.12  ±  3.26, OP 2.55  ±  0.90 p  =  0.036) (Fig.  2a, 
e, f ). As aspect, under 50 patients (CTRL) showed 
higher number of Pax7 (40.33  ±  4.42) and myogenin 
(12.01  ±  4.71) positive satellite cells respect to both 
OP and OA groups (Fig.  2a, d, g). One way Anova test 
showed a significant group effect on the expression of 
Pax7 (p = 0.0004) (Fig. 2a).
Ultrastructural characterization of satellite niches
TEM analysis was performed to characterize satellite 
cells niches and their cell syncytium. We found well con-
served sarcomere ultrastructure and numerous satellite 
cells strongly associated among them or fused to form 
a syncytium, in OA muscle biopsies (Fig.  3a–c). Con-
versely, in OP patients we observed numerous atrophic 
fibers and rare satellite cells with obvious mark of degen-
eration (Fig. 3d–f).
Immunohistochemical analysis of muscle fibers
Immunohistochemistry results of BMP-2, BMP-4, BMP-
7, myostatin and Smads1-5-8 were quantified by count-
ing the number of positive fibers (out of a total of 500 in 
randomly selected regions). As concern Smads, we also 
evaluated the number of positive nuclei (out of a total of 
500 in randomly selected regions). A significant group 
effect was detected for BMP-2 (p  =  0.0032), BMP-4 
(p  <  0.0001), BMP-7 (p  =  0.0010) (Fig.  4a), myostatin 
(p < 0.001) and nuclear Smad1-5-8 (p = 0.0003) (Fig. 5a). 
No significant group effect was found for the cytoplas-
matic expression of Smad1-5-8 (p  =  0.2610) (Fig.  4a). 
Mann–Whitney test revealed significant differences of 
BMP-2 expression in OA group as compared to OP (OA 
245.4 ± 39.21, OP 82.55 ± 19.01 p < 0.0001) (Fig. 4a–c). 
In particular, immunohistochemistry displayed an intense 
cytoplasmic reaction for BMP-2 close to regenerating fib-
ers of OA patients (Fig.  4b). In accordance to what was 
observed in terms of BMP-2, we found a significant dif-
ference on the rate of BMP-4 and BMP-7 (Fig.  4a). For 
BMP-4, Mann–Whitney test showed significant differ-
ences in OA group respect to OP (OA 76.57  ±  12.07, 
OP 46.17 ± 13.00, p = 0,0015) (Fig. 4a, e, f ). In addition, 
we also observed significant difference between OA and 
CTRL groups (p =  0.0020) (Fig.  4a). Likewise, a signifi-
cant difference in OA group respect to OP were found for 
BMP-7 expression (OA 223.70 ± 30.44, OP 76.16 ± 17.16, 
p < 0.0001) (Fig. 4a, h, i). We detected an increase in fib-
ers showing myostatin staining in OP patients as com-
pared to OA (OA 39.36  ±  7.96, OP 83.13  ±  14.46, 
p  =  0.0028) (Fig.  5a–c). As concern cytoplasmic stain-
ing of phosphorylated Smad1-5-8, no significant differ-
ences were observed between OA and OP patients (OA 
101.90 ± 15.22, OP 137.50 ± 22.92, p = 0.3106) (Fig. 5a, e, 
f ). Conversely, Mann–Whitney test displayed a significant 
difference in the nuclear expression of phosphorylated 
Smad1-5-8 in OA group as compared to OP patients (OA 
173.10 ± 27.91, OP 81.90 ± 12.03, p = 0.0136) (Fig. 5a, e, 
f ). Significant difference was also observed between OA 
and CTRL group (p = 0.0258) and OP and CTRL patients 
(p < 0.0001) (Fig. 5).
Discussions
Sarcopenia is one of the most important age-related 
human diseases. It is characterized by the loss of mus-
cle mass, strength and function. Recent studies reported 
a strong association between sarcopenia and the occur-
rence of degenerative bone diseases such as osteoporosis 
[6]. Then, the bone-muscle crosstalk could be considered 
a key element to understand the patho-physiogenesis of 
sarcopenia. In this context, our and other studies dem-
onstrated the role of BMPs in satellite cells activity and in 
the onset of sarcopenia [8, 10–13].
The main aim of this study was to test the hypothesis 
that the balance between BMPs and myostatin pathways 
regulates the age-related muscle degeneration in OP and 
OA patients. To this end, we investigated the relationship 
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among the expression of BMP-2/4-7, myostatin and 
phosphorylated Smads1-5-8 and the muscle quality, eval-
uated in term of fibers atrophy and satellite cells activity.
According to our previous studies [7, 11], morpho-
metric analysis showed an increase of the number of 
atrophic fibers in OP patients compared to OA. In par-
ticular, muscle degeneration was mainly related to type 
II fibers atrophy in OP patients. In line with these data, 
we found an high regenerative potential in muscle tis-
sues of OA patients due to the significant amount of 
Fig. 1 Mophometric analysis. Graphs show the percentage of muscle atrophic fibers in OA (a), OP (b) and CTRL (c) patients. Immunohistochemical 
analysis display type II fibers in OA (a), OP (b) and CTRL (c) group
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Pax7 positive satellite cells detected in OA group. Satel-
lite cells play an indispensable role in muscle regenera-
tion. The self-renewing proliferation of these cells not 
only maintains the stem cell population but also pro-
vides numerous myogenic cells, which proliferate, dif-
ferentiate, fuse, and lead to new myofiber formation and 
reconstitution of a functional contractile apparatus [25]. 
In addition, residual satellite cells of OP patients dis-
played signs of degeneration in niche, mitochondria and 
nucleus ultrastructural. The loss of satellite cells, and/or 
their degeneration, could reflect the alteration of muscle 
metabolism that occurs in patients affect by osteoporo-
sis. Recently, Sartori et al. highlights the role of BMPs in 
muscle metabolism. In particular, authors demonstrated 
the ability of some BMPs (mainly the BMP-2) to induce 
satellite cells activation and myofibers formation [8, 10]. 
Moreover, BMP-2 and BMP-4 can stimulate the differ-
entiation of muscle satellite cells in mature osteoblasts 
during fracture healing process [26]. In muscle environ-
ment, BMPs are produced by muscle fibers, endothe-
lial cells and, eventually, by inflammatory cells [27]. It 
is known that BMP signaling, acting through Smad1, 
Smad5 and Smad8 (Smad1-5-8) and Smad-4, regulates 
muscle regeneration in mouse models. Indeed, the inhi-
bition of BMP signaling causes muscle atrophy, abolishes 
the hypertrophic phenotype of myostatin-deficient mice 
and strongly exacerbates the effects of denervation and 
fasting [10]. Recently, we investigated the expression of 
BMP-2 and -4 in a small cohort of human muscle biop-
sies demonstrating an inverse correlation between their 
expression and muscle atrophy [11–13]. Here, we final-
ized the BMPs study investigating the expression of the 
most important BMPs involved in muscle metabolism, 
(BMP2/4 and -7), in a population of 123 patients. Our 
data clearly indicated the decrease of BMP2/4 and -7 
expression in OP patients compared to both OA group 
and CTRL. Noteworthy, we observed a remarkable dif-
ference in the expression of BMP-2 and -7 respect to 
BMP-4 in OA patients. In particular, the expression of 
BMP-2 and 7 was threefold increase compared to BMP-
4. This data suggest that BMP-4 could play a minor role 
in muscle homeostasis of adults. To circumstantiate the 
Fig. 2 Satellite cells study. a Graph display the number of Pax7 and myogenin satellite cells in OA, OP and CTRL patients. b Image shows numerous 
Pax7 positive cells in a muscle biopsy of OA patient (arrows) (40×). c Muscle tissue of OP patient characterize by no/rare Pax7 positive satellite cells 
(40×). d Image displays numerous Pax7 positive cells in a muscle biopsy of a CTRL patient (arrows) (40×). e Arrows mark myogenin positive cells in 
a muscle biopsy of OA patient (40×). f Muscle tissue of OP patient characterize by no/rare myogenin positive satellite cells (40×). g Image displays 
numerous myogenin positive satellite cells in a muscle biopsy of a CTRL patient (arrows) (40×)
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influence of BMPs signaling in sarcopenia occurrence, we 
also investigated the expression of myostatin. It is a pow-
erful negative regulator of muscle growth [18, 19]. The 
signaling triggered by the binding between myostatin and 
type II Ser/Thr kinase receptor induces the phosphoryla-
tion of Smad-2 and -3 (R-Smads) and the formation of 
R-Smad/Smad-4 complexes [18]. These complexes trans-
locate to the nucleus where they regulate the transcrip-
tion of target genes involved in muscle homeostasis [18]. 
Then, the signaling of myostatin negatively influences 
the BMPs pathways sequestering Smad-4 [8]. Our results 
showed that myostatin expression is strongly dependent 
to both aging and bone diseases. Indeed, we found higher 
levels of myostatin in OP respect to OA patients (same 
age range). A different expression profile was also found 
for phosphorylated Smad1-5-8 between OP and OA 
patients In particular, OP patients showed a low number 
of positive nuclei. The localization of Smad1-5-8 in mus-
cle fibers allowed us to obtained information about the 
balance between BMPs and myostatin signaling. Indeed, 
in presence of both myostatin and BMPs expression it is 
possible to observe an increase of cytoplasmic phospho-
rylated Smad1-5-8, whereas in samples characterized by 
no/low expression of myostatin and high expression of 
BMPs, phosphorylated Smad1-5-8 are mainly localized 
into the nucleus (Fig. 6). All together, our data displayed 
a specific molecular and histological profile of sarcopenic 
muscle tissues of OP and OA patients. In particular, mus-
cle of OP patients are characterized by (a) high number 
of atrophic fibers, (b) low number of both quiescent and 
activated satellite cells and (c) an unbalance between 
BMPs and myostatin signaling (Fig. 6). Conversely, mus-
cle tissue of OA patients showed cellular and molecular 
characteristics similar to the CTRL group (Fig. 6).
Conclusions
The identification of molecular pathways involved in the 
pathogenesis of sarcopenia open new prospective for the 
development of drugs able to prevent/treat the muscle 
impairment that occur in elderly. Results here reported, 
highlighting the role of BMPs and myostatin pathways 
in physio-pathogenesis of human sarcopenia, allow us to 
Fig. 3 Ultrastructural analysis of muscle fiber and satellite cell niches. a Image shows muscle fibers of OA patient (2500×). b Well conserved 
sarcomere structure of a muscle fibers of OA patient (20,000). c Image displays satellite cells (arrows) strongly associated among them and fused to 
form a syncytium (5000×). d Image shows atrophic fibers in OP patient (1000×). e Misaligned sarcomere in muscle tissue of OP patient (20,000×). f 
Satellite cells with obvious mark of degeneration (square) (5000×)
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propose human recombinant BMP-2/7 and anti-myosta-
tin antibodies as a possible therapeutic option for sarco-
penic patients.
Limits of the study
A possible limit of the present study could be repre-
sented by the control group. Indeed, the control patients 
showed significant age difference to the OP and OA 
groups (44 vs 73–71). Unfortunately, it is very difficult to 
collect muscle biopsies of patients over 70 without OP 
or OA who underwent hip arthroplasty for high-energy 
hip fractures. However, we believe that the data obtained 
from the control group are valid, and can improve the 
understanding of the role of BMPs and myostatin path-
ways in in muscle homeostasis. Another limit of the pre-
sent study could be represented by the different timing 
in which we performed DXA analysis on OP and OA 
patients. In particular, DXA exam was performed one 
day before surgery for OA patients and one month after 
surgery OP patients (according to our operational guide-
lines). Difference in the timing of the DXA exam could 
influence the obtained BMD values. Nevertheless, these 
Fig. 4 Immunohistochemical analysis of BMP2/4-7 expression. a Graph display the number of BMP2/4-7 muscle fibers in OA, OP and CTRL patients. 
b Image shows a muscle biopsy of OA patient with numerous BMP-2 positive fibers (4×). c Rare BMP-2 positive fibers in a muscle tissue of OP 
patient (4×). d Numerous BMP-2 positive fibers in a muscle biopsy of CTRL patient (4×). e Immunohistochemical reaction shows several BMP-4 
positive fiber in a muscle biopsy of OA patient (4×). f Image shows a muscle biopsy of OP patient with rare/no BMP-4 positive fibers (4×). g Muscle 
of a CTRL patient characterize by high expression of BMP4 (4×). h Several BMP-7 positive fibers in a muscle tissue of OA patient (4×). i Immuno-
histochemical reaction shows no/rare BMP-7 positive fiber in a muscle biopsy of OP patient (4×). j, d Numerous BMP-7 positive fibers in a muscle 
biopsy of CTRL patient (4×)
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possible discrepancies do not influence the diagnosis of 
osteoporosis given the occurrence of a low-energy femo-
ral fracture.
Abbreviations
BMD: bone mineral density; BMI: body mass index; DAB: 3,3′ Diaminoben-
zidine; DXA: dual-energy X-ray absorptiometry; H&E: hematoxylin and 
eosin; HPF: high power field; HRP: Horseradish peroxidase; JSN: joint space 
Fig. 5 Analysis of the expression of myostatin and phosphorylated Smad1-5-8. a Graph display the expression of myostatin and phosphorylated 
Smad1-5-8 in muscle biopsies of OA, OP and CTRL patients. b Rare myostatin positive fibers in a muscle tissue of OA patient (4×). c Muscle tissue of 
OP patient characterizes by numerous myostatin positive fibers (4×). d Muscle of a CTRL patient characterize by no expression of myostatin (4×). 
e Image shows muscle tissue of OA patient with numerous phosphorylated Smad1-5-8 positive nuclei (arrows) (40×). f Muscle of OP patient with 
phosphorylated Smad1-5-8 negative nuclei (arrows) (40×). g Image displays muscle biopsy of CTRL patient with numerous phosphorylated Smad1-
5-8 positive nuclei (arrows)
Fig. 6 Cellular and molecular characteristics of Sarcopenia in CTRL, OA and OP patients
Page 10 of 10Scimeca et al. J Transl Med  (2017) 15:34 
narrowing; K–L: Kellgren–Lawrence; OA: osteoarthritis; OP: osteoporosis; PAX7: 
paired box protein; SMAD: small mother against decapentaplegic; TEM: trans-
mission electron microscopy; TGF-β: transforming growth factor beta.
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